LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease

[1]  G. Bruno,et al.  Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease , 2002, Neurology.

[2]  F. Chollet,et al.  Serum lipids in young patients with ischaemic stroke: a case-control study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[3]  K. Parhofer,et al.  Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia. , 2000, Journal of lipid research.

[4]  M. Alberts,et al.  APOE genotype as a risk factor for ischemic cerebrovascular disease , 1999, Neurology.

[5]  L. Weinehall,et al.  Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. , 1999, Stroke.

[6]  E. Vicaut,et al.  Apolipoprotein(a) size polymorphism in young adults with ischemic stroke. , 1999, Atherosclerosis.

[7]  M. Margaglione,et al.  Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study. , 1998, Stroke.

[8]  Y. Kuriyama,et al.  Lipoprotein disorder in brain infarction and hemorrhage , 1998, International journal of clinical & laboratory research.

[9]  C. Kessler,et al.  The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[10]  R. Krauss,et al.  Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. , 1996, Circulation.

[11]  K. Manton,et al.  Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. , 1996, Stroke.

[12]  D. Nagaraja,et al.  Case‐control study of serum lipoprotein(a) and apolipoproteins A‐I and B in stroke in the young , 1996, Acta neurologica Scandinavica.

[13]  P. Koudstaal,et al.  Lipoprotein(a) in patients with acute cerebral ischemia. , 1996, Stroke.

[14]  A. von Eckardstein,et al.  Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. , 1996, The American journal of cardiology.

[15]  V. Hachinski,et al.  Lipids and stroke: a paradox resolved. , 1996, Archives of neurology.

[16]  J. Bogousslavsky,et al.  Stroke subtypes and hypertension. Primary hemorrhage vs infarction, large- vs small-artery disease. , 1996, Archives of neurology.

[17]  D. Kromhout.  Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.

[18]  P. Karanjia,et al.  Accuracy of initial stroke subtype diagnosis in the TOAST study , 1995, Neurology.

[19]  M. Laakso,et al.  Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. , 1995, Circulation.

[20]  M. Laakso,et al.  Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[21]  P. Ridker,et al.  Plasma concentration of lipoprotein(a) and the risk of future stroke. , 1995, JAMA.

[22]  C. Packard,et al.  Effects of ciprofibrate on LDL metabolism in man. , 1994, Atherosclerosis.

[23]  A. Slyper,et al.  Low-density lipoprotein density and atherosclerosis. Unraveling the connection. , 1994, JAMA.

[24]  G. Boysen,et al.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study , 1994, BMJ.

[25]  R. D'Agostino,et al.  Precursors of extracranial carotid atherosclerosis in the Framingham Study , 1994, Neurology.

[26]  R. Krauss,et al.  LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women , 1993, Circulation.

[27]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[28]  G. Fénelon,et al.  Prevalence of Apolipoprotein E Phenotypes in Ischemic Cerebrovascular Disease: A Case‐Control Study , 1993, Stroke.

[29]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[30]  R. Krauss,et al.  Differential effects of nicotinic acid in subjects with different LDL subclass patterns. , 1992, Atherosclerosis.

[31]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[32]  M. Giroud,et al.  Plasma lipoproteins in cortical versus lacunar infarction with or without cardiac arrhythmia, and in transient ischaemic attacks: a case control study. , 1992, Neurological research.

[33]  岡村 浩司,et al.  脳梗塞患者におけるsmall, denselow density lipoproteinの検討 , 1991 .

[34]  D. Swinkels,et al.  Single-spin density-gradient ultracentrifugation vs gradient gel electrophoresis: two methods for detecting low-density-lipoprotein heterogeneity compared. , 1991, Clinical chemistry.

[35]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  D. Swinkels,et al.  Differences in metabolism of three low density lipoprotein subfractions in Hep G2 cells. , 1990, Biochimica et biophysica acta.

[37]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[38]  R. Krauss,et al.  Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. , 1990, Circulation.

[39]  E. Schaefer,et al.  Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon. , 1989, Metabolism: clinical and experimental.

[40]  D. B. Zilversmit,et al.  Lipoproteins and the pathogenesis of atherosclerosis. , 1989, Circulation.

[41]  R Rauramaa,et al.  Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. , 1988, Arteriosclerosis.

[42]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[43]  D. Steinberg,et al.  Lipoproteins and the pathogenesis of atherosclerosis. , 1987, Circulation.

[44]  R. Krauss,et al.  GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES , 1986, The Lancet.

[45]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[46]  G. Utermann,et al.  Apolipoprotein E phenotyping from serum by Western blotting , 1986 .

[47]  R. Deitch.  Treatment of severely handicapped infants. , 1981, Lancet.

[48]  W. Kannel.  Status of coronary heart disease risk factors , 1978 .

[49]  H. Haglund.  Isoelectric focusing in pH gradients--a technique for fractionation and characterization of ampholytes. , 2006, Methods of biochemical analysis.

[50]  P. Wolf,et al.  Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. , 1970, JAMA.